ClinicalTrials.gov
public full text
Public Domain
A Phase 2 Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia
This is an efficacy study evaluating a experimental treatment for cognitive deficits in adults with schizophrenia.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)#1059708
- Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia#872625
- Comparative efficacy of various non-pharmacological therapies on cognitive function in patients with mild cognitive impairment or dementia: A network meta-analysis.#1134789
- Bromocriptine for Patients With Schizophrenia and Prediabetes#887270
- Animal Models for Drug Discovery in Schizophrenia: A Critical View from a Clinical Perspective.#662621
Record · ID 813448
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive